Bucumolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263113This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H23NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8WVJ3501L, chemically known as 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-methyl-2h-1-benzopyran-2-one but generally known as bucumolol, which bears US NIH Compound Identifier 169787. Bucumolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bucumolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05954MIG. The term BUCUMOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). BUCUMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BUCUMOLOL remains the US FDA Preferred Term for this commodity. Bucumolol bears US NLM identifiers UMLS ID C0054199 and NCI Concept Code C72611. SMILES: O(CC(O)CNC(C)(C)C)C1C2OC(=O)CCC2C(CC1)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.